Guardant Health
GH
#1169
Rank
C$27.69 B
Marketcap
C$204.72
Share price
-0.52%
Change (1 day)
51.36%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report